A vaccine is a biological preparation that improves immunity to a particular disease.
In the edible vaccine, Transgenic plants are used as vaccine production systems.
The genes encoding antigens of bacterial and viral pathogens can be expressed in plants in a form in which they retain native immunologic properties.
Edible Vaccine involves introduction of selected desired genes into plant and then inducing these altered plants to manufacture the altered protein.
These types of vaccines are antigenic proteins that are genetically engineered into a consumable crop. The strategy is that the plant food product haves the protein witch is obtained from some disease causing pathogen. People eat the plant food, the food is digested
"edible vaccines": Vaccines or candidate vaccines derived from edible plants. Transgenic plants are used as recombinant protein production systems and the edible plant tissue functions as an oral vaccine.
WHAT IS VACCINE
PROPERTIES OF IDEAL VACCINE
TYPES OF VACCINEs
TRADIONTIONAL VS EDIBLE VACCINES
EDIBLE VACCINES :- INTRO AND DEFINITION
STANDARDS FOR EDIBLE VACCINE
HISTORY OF EDIBLE VACCINE
WHY TO CHOOSE EDIBLE VACCINE?
CRITERIA FOR HOST PLANT
DEVELOPING AN EDIBLE VACCINE
METHOD OF VACCINE PRODUCTION
HOW TO MAKE EDIBLE VACCINE
HOW EDIBLE VACCINE WORK (MECHANISM)
FACTOR AFFECTING EDIBLE VACCINE
PROS OF EDIBLE VACCINE
CONS OF EDIBLE VACCINE
PLANTS USED FOR EDIBLE VACCINE PRODUCTION
PROS AND CONS OF SELECTED HOST PLANT
APPLICATION
FUTURE PROSPECTS
A vaccine is a biological preparation that improves immunity to a particular disease.
In the edible vaccine, Transgenic plants are used as vaccine production systems.
The genes encoding antigens of bacterial and viral pathogens can be expressed in plants in a form in which they retain native immunologic properties.
Edible Vaccine involves introduction of selected desired genes into plant and then inducing these altered plants to manufacture the altered protein.
These types of vaccines are antigenic proteins that are genetically engineered into a consumable crop. The strategy is that the plant food product haves the protein witch is obtained from some disease causing pathogen. People eat the plant food, the food is digested
"edible vaccines": Vaccines or candidate vaccines derived from edible plants. Transgenic plants are used as recombinant protein production systems and the edible plant tissue functions as an oral vaccine.
WHAT IS VACCINE
PROPERTIES OF IDEAL VACCINE
TYPES OF VACCINEs
TRADIONTIONAL VS EDIBLE VACCINES
EDIBLE VACCINES :- INTRO AND DEFINITION
STANDARDS FOR EDIBLE VACCINE
HISTORY OF EDIBLE VACCINE
WHY TO CHOOSE EDIBLE VACCINE?
CRITERIA FOR HOST PLANT
DEVELOPING AN EDIBLE VACCINE
METHOD OF VACCINE PRODUCTION
HOW TO MAKE EDIBLE VACCINE
HOW EDIBLE VACCINE WORK (MECHANISM)
FACTOR AFFECTING EDIBLE VACCINE
PROS OF EDIBLE VACCINE
CONS OF EDIBLE VACCINE
PLANTS USED FOR EDIBLE VACCINE PRODUCTION
PROS AND CONS OF SELECTED HOST PLANT
APPLICATION
FUTURE PROSPECTS
Vaccines have been revolutionary for the prevention of infectious diseases. Despite worldwide immunization of children against the six devastating diseases, 20% of infants are still left un-immunized; responsible for approximately two million unnecessary deaths every year, especially in the remote and impoverished parts of the globe. This is because of the constraints on vaccine production, distribution and delivery. One hundred percent coverage is desirable, because un-immunized populations in remote areas can spread infections and epidemics in the immunized safe areas, which have comparatively low herd immunity. For some infectious diseases, immunizations either do not exist or they are unreliable or very expensive. Immunization through DNA vaccines is an alternative but is an expensive approach, with disappointing immune response. Hence the search is on for cost-effective, easy-to-administer, easy-to-store, fail-safe and socio-culturally readily acceptable vaccines and their delivery systems. As Hippocrates said, Let thy food be thy medicine, scientists suggest that plants and plant viruses can be genetically engineered to produce vaccines against diseases such as dental caries; and life-threatening infections like diarrhea, AIDS, etc (Lal et al., 2007)
In nuclear biology and molecular biology, a marker gene is a gene used to determine if a nucleic acid sequence has been successfully inserted into an organism's DNA.
This PPT will provide the basic idea of Fermentation technology and it's use. The reference book is 'Pharmaceutical Biotechnology' by Giriraj Kulkarni.
this presentation deals with Molecular Ph(f)arming, and bio-safety issues related to it. This was presented by me in credit seminar in the division of Agricultural physics, IARI, New Delhi.
the sources used are duly acknowledged in the figures and slides.
Synopsis
Introduction
History
Definition
Need for edible vaccine
Plants normally used for production of
edible vaccine
Production
Mode of application
Advantages
Disadvantages
Application
Conclusion
References
Presented by- MD JAKIR HOSSAIN
Doctoral Research Scholar
Department of Agricultural Genetic Engineering ,
Faculty of Agricultural Sciences and Technologies,
Nigde Omer Halisdemir University, Turkey
E. Mail- mjakirbotru@gmail.com
Vaccines have been revolutionary for the prevention of infectious diseases. Despite worldwide immunization of children against the six devastating diseases, 20% of infants are still left un-immunized; responsible for approximately two million unnecessary deaths every year, especially in the remote and impoverished parts of the globe. This is because of the constraints on vaccine production, distribution and delivery. One hundred percent coverage is desirable, because un-immunized populations in remote areas can spread infections and epidemics in the immunized safe areas, which have comparatively low herd immunity. For some infectious diseases, immunizations either do not exist or they are unreliable or very expensive. Immunization through DNA vaccines is an alternative but is an expensive approach, with disappointing immune response. Hence the search is on for cost-effective, easy-to-administer, easy-to-store, fail-safe and socio-culturally readily acceptable vaccines and their delivery systems. As Hippocrates said, Let thy food be thy medicine, scientists suggest that plants and plant viruses can be genetically engineered to produce vaccines against diseases such as dental caries; and life-threatening infections like diarrhea, AIDS, etc (Lal et al., 2007)
In nuclear biology and molecular biology, a marker gene is a gene used to determine if a nucleic acid sequence has been successfully inserted into an organism's DNA.
This PPT will provide the basic idea of Fermentation technology and it's use. The reference book is 'Pharmaceutical Biotechnology' by Giriraj Kulkarni.
this presentation deals with Molecular Ph(f)arming, and bio-safety issues related to it. This was presented by me in credit seminar in the division of Agricultural physics, IARI, New Delhi.
the sources used are duly acknowledged in the figures and slides.
Synopsis
Introduction
History
Definition
Need for edible vaccine
Plants normally used for production of
edible vaccine
Production
Mode of application
Advantages
Disadvantages
Application
Conclusion
References
Presented by- MD JAKIR HOSSAIN
Doctoral Research Scholar
Department of Agricultural Genetic Engineering ,
Faculty of Agricultural Sciences and Technologies,
Nigde Omer Halisdemir University, Turkey
E. Mail- mjakirbotru@gmail.com
Plant Disease Resistant And Genetic EngineeringShweta Jhakhar
Study the adverse effects of different viruses and other fungal diseases on the plants and their growth. Discuss the methods e.g. plant disease resistant and genetic engineering to protect the plants.
The development and commercialization of insect-resistant transgenic Bt crops expressing Cry toxins revolutionized the history of agriculture. At the end of 2010, an estimated 26.3 million hectares of land were planted with crops containing the Bt gene (James 2011). Bt cotton has reduced the use of traditional insecticides by 207,900,000 lbs of active ingredient of insecticide (Brookes and Barfoot, 2006).
Resistance is a genetic change in the insect pest — that allows it to avoid harm from Bt toxins. The high and consistent levels of ICP production in the Bt plants make them much less favorable for the development of resistance. Insect Resistance Management is of great importance because of the threat insect resistance poses to the future use of Bt plant-incorporated protectants and is said to be the key to sustainable use of the genetically modified Bt crops. The US EPA usually requires a “buffer zone,” or a structured refuge of 20% non-Bt crops that is planted in close proximity to the Bt crops.
First documented case of insect resistance to Bt cotton came in 2008, when Tabashnik and coworkers found field-evolved Bt toxin resistance in bollworm, Helicoverpa zea (Boddie), in the United States. Field-Evolved Resistance to Bt Maize by Western Corn Rootworm (Gassmann, 2011) displayed significantly higher survival on Cry3Bb1 maize in laboratory bioassays.
Expanded use of transgenic crops for insect control will likely include more varieties with combinations of two or more Bt toxins (pyramiding), novel Bt toxins such as VIP, modified Bt toxins that have been genetically engineered to kill insects resistant to standard Bt toxins. Transgenic plants that control insects via RNA interference are also under development.
Increasing use of transgenic crops in developing nations is likely, with a broadening range of genetically modified crops and target insect pests .Incorporating enhanced understanding of observed patterns of field-evolved resistance into future resistance management strategies can help to minimize the drawbacks and maximize the benefits of current and future generations of transgenic crops.
Edible vaccines hold great promise as a cost-effective, easy-to-administer, easy-to-store, fail-safe and socioculturally readily acceptable vaccine delivery system, especially for the poor developing countries. It involves introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins. Introduced as a concept about a decade ago, it has become a reality today. A variety of delivery systems have been developed. Initially thought to be useful only for preventing infectious diseases, it has also found application in prevention of autoimmune diseases, birth control, cancer therapy, etc. Edible vaccines are currently being developed for a number of human and animal diseases. There is growing acceptance of transgenic crops in both industrial and developing countries. Resistance to genetically modified foods may affect the future of edible vaccines. They have passed the major hurdles in the path of an emerging vaccine technology. Various technical obstacles, regulatory and non-scientific challenges, though all seem surmountable, need to be overcome. This review attempts to discuss the current status and future of this new preventive modality.
Presentation of Edible Vaccine, Properties of an edible vaccine, how to make an edible vaccine, and etc.
An edible vaccine is the best vaccine for developing country because of it very cost effective and very simple to use.
But our country has not developed this vaccine yet. So it is our responsibility to develop an edible vaccine to protect our human being form more infectious disease.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
1. EDIBLE
VACCINES-A
new approach to oral
immunization
Presented by- Anurag Chanda
B.Pharm 3rd Year, 6th semester
18601911014
2. Introduction-
Plants offer enormous potential as
production platform for vaccines
The stable integration of a gene into
the plant nuclear or chloroplast
genome can transform plants like
tobacco, potato, tomato, banana into
bioreactors for the production of sub-unit
vaccines.
Owing to its low cost of production it is
suitable for developing countries like
India
3.
4. Advantages
- Edible means of administration.
Reduced means of medical
personnel and sterile injection
conditions.
Economical in mass production
and transportation.
Heat stable and eliminating the
use of refrigeration.
Delivery of multiple antigens.
5. Plant
species-
Potato :
Advantage
Easily transformed.
Easily propagated.
Stored for long periods without
refrigeration.
Disadvantage
Need cooking which denature
antigen.
Banana
Advantages
Do not need cooking.
Protein not destroyed even after
cooking.
Inexpensive .
Grown widely in developing
countries.
Disadvantages
Trees take 2-3 to mature years.
Spoils rapidly after ripening.
Rice
Advantages
Commonly used in baby food.
High expression of antigen.
Disadvantages
Grows slowly.
Requires glasshouse condition.
Tomato
Advantage
Grow quickly.
Cultivate broadly.
High content Vitamin-A may boost
immune response.
Disadvantages
Spoils readily.
6.
7. Oral delivery, mucosal and
systemic antibody responses-
Plant derived vaccines have
demonstrated the ability to induce
both systemic and mucosal immune
responses.
The major obstacle to oral vaccination
is the digestion of the antigenic protein
in the stomach.
Vaccines derived and delivered by
plant cells have been shown to over
come this problem through the
protective effect of the plant cell wall.
8.
9. A unique opportunity against the threat of
bio-weapons
•A number of infectious diseases, including smallpox,
anthrax, and plague have recently raised concern for
their possible use in the actions of bio-terrorism.
•Nations at risk are now faced with the need to be
ready to vaccinate part of all their population within
limited periods of time.
•This means that millions of vaccine does have to be
prepared, stored and renewed at intervals of time.
•The economic and technical benefits offered by plant
derived vaccines propose these as the ideal
substitutes fro traditional vaccines.
•Research on plants that produce antigens against
major pathogens feared in case of bio-terrorism is
already under way.
10. Dosage- to explain the concept of oral therapeutic protein delivery ,
Hepatitis B surface antigen(HBsAg) was used for oral immunization. No
primary immune response was detected after two 300 microgram doses
of yeast derived HBsAg. However a primary immune response began
after two servings of transgenic potatoes containing, 85-300micrograms
of HBsAg.
Side effects- A research by National Institute Of Allergy &
Infectious Diseases(NIAID), National Institute Of Health(NIH) and
Maryland School Of Medicine showed no significant side effects.
Limitations-
•Development of immune tolerance to vaccine peptide or
protein.
•Consistency of dosage from fruit to fruit and from plant to
plant and from generation to generation is not similar.
•Selection of best plant in difficult.
•Certain foods like potato are not eaten raw and cooking
the food might weaken the medicine present in it.
11. Plant-based production of biopharmaceuticals.
Rainer Fischer, Eva Stoger, Stefan Schillberg, Paul Christou and
Richard M Twyman, Current Opinion in Plant Biology 2004, 152–
158.
Edible vaccines: a new approach to oral immunization.
Neeraj Mishra, Prem N Gupta, Kapil Khatri, amit K Goyal, Suresh P
Vyas. Indian Journal Of Biotechnology.283-294.
Edible Vaccines by William H.R Langridge.
Scientific American. 66-71
